Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs
Infection and Drug Resistance · 2026-01 · Volume 19 · 1-12
DOI: 10.2147/idr.s564580 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2026-01. Verfasst von Kun He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, People's Republic of China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, People's Republic of China.
Zitieren
APA
He, K., Zhang, J., Du, X., He, X., Zeng, Y., & Liu, M. (2026). Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. Infection and Drug Resistance, Volume 19, 1-12. https://doi.org/10.2147/idr.s564580
Vancouver
He K, Zhang J, Du X, He X, Zeng Y, Liu M. Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. Infection and Drug Resistance. 2026;Volume 19:1-12. doi:10.2147/idr.s564580
BibTeX
@article{He2026,
author = {He, Kun and Zhang, Jing and Du, Xiang and He, Xiaoqing and Zeng, Yanming and Liu, Min},
title = {Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--12},
doi = {10.2147/idr.s564580}
}
EUVIMED